Cytomegalovirus Infection

Abdullah, 1976, Diagnosis of cytomegalovirus pneumonia in compromised hosts, Am J Med, 61, 326, 10.1016/0002-9343(76)90368-5 Apperly, 1985, Foscarnet for cytomegalovirus pneumonitis, Lancet, i, 1151, 10.1016/S0140-6736(85)92447-X Broaddus, 1985, Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infection in AIDS, Ann Intern Med, 102, 747, 10.7326/0003-4819-102-6-747 Brodie, 1985, Is cytomegalovirus a cause of lung disease in patients with AIDS? (abstract), Clin Res, 33, 396A Cederberg D, Laskin OL, Mills J, et al: Efficacy and safety of 9-(2-hydroxy-l-(hydroxymethyl)ethoxymethyl)guanine (BW759U) in AIDS patients with cytomegalovirus retinitis (abstract). 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 1986, New Orleans, Abstract 565, p 200 Chachoua, 1987, 9-(1, 3-dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome, Ann Intern Med, 107, 133, 10.7326/0003-4819-107-2-133 Cohen, 1985, Cytomegalovirus infection in the normal host, Medicine, 64, 100, 10.1097/00005792-198503000-00003 Cole NL, Balfour HH: Does cytomegalovirus become more resistant during antiviral therapy? (abstract). 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Minneapolis, 1985, Abstract 128, p 113 Collaborative DHPG Treatment Study Group, 1986, Treatment of serious cytomegalovirus infections with 9-(1,3 dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies, N Engl J Med, 314, 801, 10.1056/NEJM198603273141301 Debs R, Brunette E, Papahadjopoulous D, et al: Site specific therapy of murine cytomegalovirus lung infection using aerosolized antiviral agents. 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1986, New Orleans, Abstract 730, p 231 Drew, 1985, Cytomegalovirus infection and abnormal t-lymphocyte subset ratios in homosexual men, Ann Intern Med, 10, 61, 10.7326/0003-4819-103-1-61 Elion GB: History, mechanism of action, spectrum and selectivity of nucleoside analogs. In Mills J, Corey L (eds): Antiviral Chemotherapy: New Directions for Clinical Application and Research, New York, American Elsevier Publishing Co, 1986, p 127 Evenhouse, 1987, Hypotension in infection with the human immunodeficiency virus (letter), Ann Intern Med, 107, 598, 10.7326/0003-4819-107-4-598_1 Field, 1983, 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl)guanine: A selective inhibitor of herpes group virus replication, Proc Natl Acad Sci USA, 80, 4139, 10.1073/pnas.80.13.4139 Fletcher C, Sawchuck R, Chinnock B, et al: Human pharmacokinetics of 9-(2-hydroxy-l-hydroxy-methyl)ethoxymethyl)guanine (abstract). 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology. 1985, Minneapolis, Abstract 127, p 113 Freitas, 1985, Activity of 9-(1,3-dihydroxy-2-propoxy)methyl)guanine compared with that of acyclovir against human monkey and rodent cytomegalovirus, Antimicrob Agents Chemother, 28, 240, 10.1128/AAC.28.2.240 Holland, 1986, Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome: Use of the experimental drug 9-(2-hydroxy-l-(hydroxymethyl)-ethoxymethyl)guanine, Arch Ophthalmol, 104, 1794, 10.1001/archopht.1986.01050240068042 Jacobson, 1987, Oral ganciclovir: Human pharmacokinetics and tolerance, Antimicrob Agents Chemother, 31, 1251, 10.1128/AAC.31.8.1251 Jacobson MA, O'Donnell JJ, Porteus D, et al: Natural history of ganciclovir-treated cytomegalovirus retinitis and gastrointestinal disease (abstract). 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1987, New York, Abstract 836, p 243 Jordan, 1983, Latent infection and the elusive cytomegalovirus, J Infect Dis, 5, 205 Kennedy, 1986, Cytomegalovirus but not human T lymphotropic virus type III detected by in situ hybridization in retinal lesions in patients with AIDS, Br Med J, 293, 161, 10.1136/bmj.293.6540.162 Klintmalm, 1985, Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients, Scand J Infect Dis, 17, 157, 10.3109/inf.1985.17.issue-2.06 Laskin, 1987, Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS, J Infect Dis, 155, 323, 10.1093/infdis/155.2.323 Mar, 1983, Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro., Antimicrob Agents Chemother, 24, 518, 10.1128/AAC.24.4.518 Masur, 1986, Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men, Ann Intern Med, 104, 41, 10.7326/0003-4819-104-1-41 Meyers J: Immunoprophylaxis and immunotherapy of CMV infections. 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1987, New York, Session 89 Mills, 1986, (-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) for treatment of cytomegalovirus infections, 199 Minozzi C: Cytomegalovirus in bronchoalveolar lavage of AIDS patients with Pneumocystis carinii pneumonia (abstract). 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1987, New York, Abstract 835, p 243 Mintz, 1983, Cytomegalovirus infections in homosexual men: An epidemiologic study, Ann Intern Med, 98, 326, 10.7326/0003-4819-99-3-326 Murray, 1984, Pulmonary complications of the acquried immunodeficiency syndrome: Report of a National Heart, Lung and Blood Institute Workshop, N Engl J Med, 310, 1682, 10.1056/NEJM198406213102529 Pass, 1984, Thoracic manifestations of the acquired immunodeficiency syndrome, J Thorac Cardiovasc Surg, 88, 654, 10.1016/S0022-5223(19)35432-7 Quinnan, 1984, Herpes virus infections in the acquired immune deficiency syndrome, JAMA, 252, 72, 10.1001/jama.1984.03350010038020 Reed, 1986, Treatment of cytomegalovirus pneumonia with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl)guanine and high dose corticosteroids, Ann Intern Med, 105, 214, 10.7326/0003-4819-105-2-214 Reed EC, Bowden RA, Dandliker PS, Meyers JD: The efficacy of cytomegalovirus immune globulin in marrow transplant patients with CMV pneumonia (abstract). 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1986, New Orleans, Abstract 731, p 231 Reichert, 1983, Autopsy pathology in the acquired immune deficiency syndrome, Am J Pathol, 12, 357 Shepp, 1985, Activity of 9-(2-hydroxy-1(hydroxymethyl)ethoxymethyl)guanine in the treatment of cytomegalovirus pneumonia, Ann Intern Med, 103, 368, 10.7326/0003-4819-103-3-368 Silverman, 1985, Serum lactate dehydrogenase levels in adults and children with acquired immunodeficiency syndrome: Possible indicator of B cell lymphoproliferative and disease activity. Effect of intravenous gammaglobulin on enzyme levels, Am J Med, 78, 728, 10.1016/0002-9343(85)90275-X Stover, 1984, Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host, Ann Intern Med, 101, 1, 10.7326/0003-4819-101-1-1 Stover, 1985, Spectrum of pulmonary diseases associated with the acquired immunodeficiency syndrome, Am J Med, 78, 429, 10.1016/0002-9343(85)90334-1 Tocci, 1984, Effect of the nucleoside analogue 2’-NDG on cytomegalovirus replication, Antimicrob Agents Chemother, 25, 247, 10.1128/AAC.25.2.247 Wallace, 1987, Cytomegalovirus pneumonitis in patients with AIDS: Findings in an autopsy series, Chest, 92, 198, 10.1378/chest.92.2.198 Winston, 1987, Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation, Ann Intern Med, 106, 12, 10.7326/0003-4819-106-1-12